American Society of Hematology/LinkedIn
Sep 5, 2026, 04:56
Opportunities for the Next Generation of Hematologists – American Society of Hematology
American Society of Hematology shared a post on LinkedIn:
“ASH invests in the next generation of hematologists and researchers.
Applications are now open for several ASH Awards offering research funding, mentorship, protected research time, and career development support.
ASH’s universal award application is a streamlined process that lets eligible medical students, residents, and graduate students submit one application and be considered for multiple ASH award programs at their career level.
Explore available awards and find the opportunity that fits your career stage.
Know someone who may be eligible? Share these opportunities with them.”

Other posts featuring American Society of Hematology on Hemostasis Today.
Academic Medicine
American Society of Hematology
ASH
Career Development
Career Support
Clinical Research
Future Hematologists
Headlines
healthcare
Hematology
Hematology Research
Hemostasis News
Hemostasis Today
medical education
Medical Research
Medical Students
Mentorship
Research Funding
Research Opportunities
-
Sep 5, 2026, 04:51Samuel Nwokolo: The Bone Marrow Factory – Anatomy of Blood Production
-
Sep 5, 2026, 04:37Maryam Alaa Alsaid: Diagnostic Puzzle of Sickle Beta Thalassemia
-
Sep 5, 2026, 04:16Key Cardiovascular Insights from ESC Congress
-
Sep 5, 2026, 03:30Rob Maloney: Who Are the Real Experts? – The Quiet Resilience of the Bleeding Disorders Community
-
Sep 5, 2026, 03:26Project Elevate Her – Scaling Heights for Bleeding Disorders Awareness – WFH
-
Sep 5, 2026, 03:20Sarah Bassiony: How Do non-Specialists Learn Haematology? – Participate in Our Remote Study
-
Sep 5, 2026, 03:13Omid Seidizadeh: Uncovering the Genetic Architecture of Low Von Willebrand Factor
-
Sep 5, 2026, 03:07Luke McLaughlin: The First Community Article of the Haemophilia Rights Project
-
Sep 5, 2026, 03:00Panagiotis Christoforou: Proud to Contribute to Barts Health’s Leading Role in UK Clinical Trials